Physician profile
Seth Barker
NPI 1538747571
$498.39
in general payments reported to CMS, 2019-2025
11 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.89 · 2023: $124 · 2024: $196 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $110.47 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $109.12 | 2024 | Wainua |
| Amgen INC. | $54.13 | 2024-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $46.36 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $44.38 | 2024 | Injectafer |
| Edwards Lifesciences Corporation | $36.20 | 2023-2024 | |
| Pelvital USA, INC. | $27.55 | 2025 | |
| Inspire Medical Systems, INC. | $21.27 | 2025 | Inspire |
| Xeris Pharmaceuticals, INC. | $18.19 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $17.89 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.83 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.